Showing 161 - 180 results of 180 for search '(( significant ((main decrease) OR (a decrease)) ) OR ( significant optimization data ))~', query time: 0.96s Refine Results
  1. 161

    Example images from four plant datasets. by Dunlu Lu (19964225)

    Published 2024
    “…The curated data and code can be accessed at the following link: <a href="https://github.com/YangxuWangamI/MAR-YOLOv9" target="_blank">https://github.com/YangxuWangamI/MAR-YOLOv9</a>.…”
  2. 162

    Counting results on RFRB dataset. by Dunlu Lu (19964225)

    Published 2024
    “…The curated data and code can be accessed at the following link: <a href="https://github.com/YangxuWangamI/MAR-YOLOv9" target="_blank">https://github.com/YangxuWangamI/MAR-YOLOv9</a>.…”
  3. 163

    Detection visualization results on WEDU dataset. by Dunlu Lu (19964225)

    Published 2024
    “…The curated data and code can be accessed at the following link: <a href="https://github.com/YangxuWangamI/MAR-YOLOv9" target="_blank">https://github.com/YangxuWangamI/MAR-YOLOv9</a>.…”
  4. 164

    Table 1_Inflammation and nutritional status in relation to mortality risk from cardio-cerebrovascular events: evidence from NHANES.docx by Chengzhi Hou (20419865)

    Published 2024
    “…To the left of this inflection, each unit increase in ALI was associated with a 1.3% decrease in all-cause and cardiovascular mortality risk among MACCE patients. …”
  5. 165

    Image 1_Inflammation and nutritional status in relation to mortality risk from cardio-cerebrovascular events: evidence from NHANES.tif by Chengzhi Hou (20419865)

    Published 2024
    “…To the left of this inflection, each unit increase in ALI was associated with a 1.3% decrease in all-cause and cardiovascular mortality risk among MACCE patients. …”
  6. 166

    Mortality of women of fertile age between 2006 and 2019: causes and trends by Silmara Bruna Zambom Albert (14516704)

    Published 2023
    “…For the analyzed period, after standardization, the mortality rate due to diseases of the circulatory and respiratory systems, and infectious and parasitic conditions showed a decreasing trend, with a significant drop of 26.6% for diseases of the circulatory system; while external causes and neoplasms showed an increasing trend from 2006 to 2012 and decreasing from 2013 onwards. …”
  7. 167

    Table_1_Characterization of Acute Poisoning in Hospitalized Children in Southwest China.XLSX by Zhu Li (193162)

    Published 2021
    “…The overall number of hospitalizations presented a decreasing trend, while the number of urban children gradually increased. …”
  8. 168

    Table_2_Characterization of Acute Poisoning in Hospitalized Children in Southwest China.xls by Zhu Li (193162)

    Published 2021
    “…The overall number of hospitalizations presented a decreasing trend, while the number of urban children gradually increased. …”
  9. 169

    Table 1_Neuropsychological outcome of indoor rehabilitation in post-COVID-19 condition—results of the PoCoRe study.docx by Michael Jöbges (12363520)

    Published 2025
    “…</p>Results<p>Out of the 1,086 recruited participants, a total of N = 701 participants were included in the main data analysis. …”
  10. 170

    Table 2_Neuropsychological outcome of indoor rehabilitation in post-COVID-19 condition—results of the PoCoRe study.docx by Michael Jöbges (12363520)

    Published 2025
    “…</p>Results<p>Out of the 1,086 recruited participants, a total of N = 701 participants were included in the main data analysis. …”
  11. 171

    Image_1_Low LH Level on the Day of GnRH Agonist Trigger Is Associated With Reduced Ongoing Pregnancy and Live Birth Rates and Increased Early Miscarriage Rates Following IVF/ICSI T... by Abdelhamid Benmachiche (7397495)

    Published 2019
    “…</p><p>Design: This study is based on data from a previously published randomized controlled trial conducted from 2014 to 2016.…”
  12. 172

    Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells by Sebastian Krug (832777)

    Published 2019
    “…SSTR modulation via lanreotide moderately influenced proliferation, mainly via modulating AKT and ERK signalling, which was paralleled by decreased chromogranin A (CgA) expression and secretion. …”
  13. 173

    Table 1_The relationship between the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (NHHR) and both MASLD and advanced liver fibrosis: ev... by Juyi Li (8996117)

    Published 2025
    “…Elevated NHHR levels in the Q2 and Q3 groups remained significantly linked to a decreased risk of advanced liver fibrosis, with odds ratios of 0.61 (95% CI 0.40–0.94, P = 0.03) and 0.64 (95% CI 0.47–0.89, P = 0.01), respectively. …”
  14. 174

    Table 5_The relationship between the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (NHHR) and both MASLD and advanced liver fibrosis: ev... by Juyi Li (8996117)

    Published 2025
    “…Elevated NHHR levels in the Q2 and Q3 groups remained significantly linked to a decreased risk of advanced liver fibrosis, with odds ratios of 0.61 (95% CI 0.40–0.94, P = 0.03) and 0.64 (95% CI 0.47–0.89, P = 0.01), respectively. …”
  15. 175

    Table 4_The relationship between the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (NHHR) and both MASLD and advanced liver fibrosis: ev... by Juyi Li (8996117)

    Published 2025
    “…Elevated NHHR levels in the Q2 and Q3 groups remained significantly linked to a decreased risk of advanced liver fibrosis, with odds ratios of 0.61 (95% CI 0.40–0.94, P = 0.03) and 0.64 (95% CI 0.47–0.89, P = 0.01), respectively. …”
  16. 176

    Table 2_The relationship between the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (NHHR) and both MASLD and advanced liver fibrosis: ev... by Juyi Li (8996117)

    Published 2025
    “…Elevated NHHR levels in the Q2 and Q3 groups remained significantly linked to a decreased risk of advanced liver fibrosis, with odds ratios of 0.61 (95% CI 0.40–0.94, P = 0.03) and 0.64 (95% CI 0.47–0.89, P = 0.01), respectively. …”
  17. 177

    Table 3_The relationship between the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (NHHR) and both MASLD and advanced liver fibrosis: ev... by Juyi Li (8996117)

    Published 2025
    “…Elevated NHHR levels in the Q2 and Q3 groups remained significantly linked to a decreased risk of advanced liver fibrosis, with odds ratios of 0.61 (95% CI 0.40–0.94, P = 0.03) and 0.64 (95% CI 0.47–0.89, P = 0.01), respectively. …”
  18. 178

    Image_1_Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment.tif by Daniela Gallo (396073)

    Published 2022
    “…Combination therapy resulted in a significantly greater reduction in serum FT4 concentration at 45 days (-37.9 pg/ml, CI 95%, -43.7 to -32.2 pg/ml) and 180 days (-36.5 pg/ml, CI 95%, -42 to -30.9 pg/ml) compared to MMI monotherapy (respectively: -25.7 pg/ml, CI 95%, -31.6 to -19.7 pg/ml and -22.9 pg/ml, CI 95%, -28 to -17.3 pg/ml, p 0.002). …”
  19. 179

    Table_1_Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment.docx by Daniela Gallo (396073)

    Published 2022
    “…Combination therapy resulted in a significantly greater reduction in serum FT4 concentration at 45 days (-37.9 pg/ml, CI 95%, -43.7 to -32.2 pg/ml) and 180 days (-36.5 pg/ml, CI 95%, -42 to -30.9 pg/ml) compared to MMI monotherapy (respectively: -25.7 pg/ml, CI 95%, -31.6 to -19.7 pg/ml and -22.9 pg/ml, CI 95%, -28 to -17.3 pg/ml, p 0.002). …”
  20. 180

    Table_2_Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment.docx by Daniela Gallo (396073)

    Published 2022
    “…Combination therapy resulted in a significantly greater reduction in serum FT4 concentration at 45 days (-37.9 pg/ml, CI 95%, -43.7 to -32.2 pg/ml) and 180 days (-36.5 pg/ml, CI 95%, -42 to -30.9 pg/ml) compared to MMI monotherapy (respectively: -25.7 pg/ml, CI 95%, -31.6 to -19.7 pg/ml and -22.9 pg/ml, CI 95%, -28 to -17.3 pg/ml, p 0.002). …”